Rheumatologists’ bDMARDs prescribing the target of government-funded program

Specialists’ prescribing of bDMARDs is being put under the spotlight by a new NPS MedicineWise-led program that aims to get the “best health and economic outcomes” for use of the expensive drugs. Rheumatologists and clinical immunologists are the first target of the Value in Prescribing bDMARDs Program which will see them sent reports on their ...

Already a member?

Login to keep reading.

© 2021 the limbic